WY vs XENE · P/E 43, rev $3.59B vs $2.55B cap
Weyerhaeuser Company (WY) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
WY currently screens at market cap $17.54B and trailing P/E 43.4. XENE currently screens at market cap $2.55B.
Not investment advice. Open the WY and XENE stock pages for the full models.
Not investment advice.